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    食管癌是一种高发的致命性恶性肿瘤，这些年来在美国及其他发达国家的










 Bid （BH3 interacting death agonist）是一个具有多种功能的且只含有 BH3




    本论文系研究苦参碱在人食管癌细胞体内、体外抗癌的机制。首先，苦参
碱在细胞培养过程中，对细胞存活率呈时间-剂量依赖的关系，并且通过上调蛋
白 p53 和 p27 诱导细胞凋亡，使人食管癌细胞周期阻滞在 G0/G1 期，苦参碱对
凋亡通路上关键蛋白的调节也促进了人食管癌细胞的凋亡。而后将食管癌鳞状
细胞 Eca-109 对裸鼠进行皮下成瘤实验并对肿瘤进行解剖分析。实验证明苦参


















   促进凋亡因子（AIF)激活依赖 caspase 和非依赖 caspase 通路。PARP 是非依
赖 caspase 凋亡通路的重要活化因子，DNA 破坏后生成 PAR 的聚合物。过度激




引起细胞凋亡。实验证明细胞内总 AIF 表达量和细胞质内 AIF 表达量在苦参碱
诱导下在并未出现有意义的量的变化。我们推测在人食管癌细胞凋亡中 AIF 介



















Esophageal cancer is one of the deadliest cancers and the incidence of 
esophageal adenocarcinoma has increased rapidly in the United States and other 
developed countries in recent years. In 2011, 167200 estimated new cases were 
diagnosed, with a high incidence of new cases in China. Although esophageal 
squamous cell carcinoma with surgical treatment is given priority to, local 
radiotherapy and auxiliary chemical drug therapy are equal important in prognosis. 
However esophageal cancer is highly resistant to chemotherapy. Therefore, 
discovery of novel drugs to treat esophageal cancer is essential. 
Matrine, a member of Sophora family, is an alkaloid found in plants, and 
produces plethora pharmacological effects, including anti-cancer effects. Studies 
confirmed that matrine can inhibit a variety of tumor cells, for example, hela, gastric 
tumor, colorectal carcinoma, osteosarcoma， etc. However, the mechanism involved 
remains largely unknown. Bid, a BH3 domain-only agonist, is a BH3-only Bcl-2 
family member with multiple functions. Studies suggest that Bid has dual functions 
on inducing apoptosis and DNA damage repair in cells. It can also induce the 
activation of different signaling pathways to promote or inhibit the tumor 
development, and it can show different biological functions in different research 
systems. 
This study is conducted to investigate the anti-cancer mechanisms of matrine in 
human esophageal cancer in vitro and in vivo. In human esophageal cancer cell 
Eca-109 culture, matrine significantly decreases the cell viability in a 
dose-dependent manner, and induces apoptosis as well as cell cycle arrest in G0/G1 
phase by up-regulation of p53 and p21. By regulating the expression of the apoptosis 
pathway's key proteins, matrine induced the human esophageal cancer cells. Eca-109 
esophagus tumor has been obtained by implanted the tumor cells into nude BALB/c 














were evaluated by Western blot analysis. We found that matrine decreased cell 
viability by inducing cell apoptosis of the down-regulation of the ratio of BCL-2/Bid 
and increasing activation of caspase-9. Further studies indicated that matrine induced 
ap-optosis of Eca-109 was through the mitochondria-mediated internal pathwa-y, but 
not by death receptor-mediated extrinsic apoptotic pathway, which was confirmed by 
Bid translocated from the nuclear to mitochondria during the procession of the 
apoptosis induced by matrine. In vivo study found that matrine effectively inhibited 
the tumor formation of Eca-109 cells in nude mice. 
Apoptosis-inducing factor (AIF), which activates caspase-dependent and 
caspase-independent cell death. PARP is emerging as an important activator of 
caspase -independent cell death, generates the PAR polymers following DNA 
damage. Overactivation of PARP initiates a nuclear signal that propagates to 
mitochondria and triggers the release of AIF, then AIF shuttles from mitochondria to 
the nucleus and induces peripheral chromatin condensation, large-scale 
fragmentation of DNA and ultimately cytotoxicity . Our investigation have proved 
that matrine can increase the PARP degradation. And we also find that matrine locats 
into the nucleus, triggers this caspase-independent way to induce peripheral 
chromatin condensation, then leading the cell cytotoxicity. We proved the total AIF 
has no change either in the drug treated group or the drug-free group, the same 
situation is showed in the cytoplasm. We infered that AIF caspase-independent 
pathway is not involved in Eca-109 cell apoptosis. 
Our study suggests that matrine could serve as a potential novel agent from 
natural products to treat esophageal cancer. 
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图 1-1 苦参碱的化学结构 


































   肿瘤细胞发生发展的重要生物学特征之一便是无限制增殖。为了观察苦参碱
对人胶质瘤细胞株U251 细胞生长的影响，已有研究采用MTT 比色法，发现随着
苦参碱药物处理浓度的增加, 对肿瘤细胞的增殖抑制作用逐渐增强。与空白对
照相比,苦参碱低浓度处理时（0. 025 和0. 05  g /L），对肿瘤细胞的抑制作用
较弱，但是随着浓度的增大达到0.10 g/L时，对肿瘤细胞具有明显的抑制作用。
真核细胞内重要的转录因子---C-myc, 参与细胞增殖和凋亡调控，诱导下游基
因 mRNA 转录和蛋白表达, 其表达的异常增加使细胞增殖和凋亡的动态平衡遭
到破坏, 从而诱导细胞转化和形成肿瘤[3] 。采用用RT-PCR方法，观察原癌基因
C-myc 表达情况, 结果表明，随着苦参碱作用剂量的增加, C-myc 基因的表达
出现明显被抑制的作用,由此推断苦参碱使U251细胞中原癌基因C-myc表达受到
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细胞增殖产生抑制[5] 。同样具有促肿瘤细胞增殖作用的还有甲胎蛋白( AFP)




    肿瘤细胞的重要生物学特征之一--分化不良。以有研究显示, 0. 1g /L 苦
参碱能诱导白血病细胞K562的分化,白血病细胞K562形态上类似于中幼红和晚
幼红细胞。测得的联苯胺染色阳性率由1% ~ 2% 上升至7%,同时，细胞化学染色
结果显示糖原由阴性转为100%强阳性。实验表明苦参碱对K562细胞的作用呈时
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理上不需要的细胞, 以维持机体的自我稳定性, 并不伤害到整个机体。 
1.1.2 苦参碱抗肿瘤细胞黏附与浸润转移 
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